DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
37 hedge funds and large institutions have $65.1M invested in Dicerna Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
37
Holding in Top 10
1
Calls
$31K
Puts
–
Top Buyers
| 1 | +$1.9M | |
| 2 | +$1.09M | |
| 3 | +$606K | |
| 4 |
MC
Matisse Capital
Portland,
Oregon
|
+$575K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$554K |
Top Sellers
| 1 | -$5.05M | |
| 2 | -$602K | |
| 3 | -$507K | |
| 4 |
6CM
683 Capital Management
New York
|
-$229K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$59.3K |